These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2934730)

  • 21. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does the use of ticlopidine in chronic hemodialysed patients contra- indicate renal transplantation? A false problem?].
    Moriniere P; Pourchez T; Renaud H
    Presse Med; 1986 Oct; 15(33):1689. PubMed ID: 2947127
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-platelet drugs during chronic hemodialysis: an experience with ticlopidine, the 5-(o-chlorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c] pyridine.
    Bono F; De Gasperi T; Zanelli P; Menta R; Castiglioni A; Savazzi GM; Cambi V
    Farmaco Prat; 1983 Dec; 38(12):451-5. PubMed ID: 6662220
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
    Tohgi H
    Agents Actions Suppl; 1984; 15():279-82. PubMed ID: 6385652
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of hemorrhage with the target-specific oral anticoagulants.
    Pluym M; Howell G
    Hosp Pract (1995); 2014 Aug; 42(3):75-83. PubMed ID: 25255409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in arterial blood gases after hemodialysis and the influence of platelet antiaggregation].
    Méndez Martín A; Ortiz González A; Gutiérrez González JR
    Med Clin (Barc); 1984 May; 82(20):885-8. PubMed ID: 6431205
    [No Abstract]   [Full Text] [Related]  

  • 28. Dialysis patients refusing kidney transplantation: data from the Slovenian Renal Replacement Therapy Registry.
    Buturović-Ponikvar J; Gubenšek J; Arnol M; Bren A; Kandus A; Ponikvar R
    Ther Apher Dial; 2011 Jun; 15(3):245-9. PubMed ID: 21624070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dialysis and renal transplantation: update 2015].
    Riegel W; Krüger B
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1831-4. PubMed ID: 26625233
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of cyclosporin A, ticlopidine hydrochloride and cobra venom factor on the hyperacute rejection of discordant renal xenografts.
    Green CJ; Kemp E; Kemp G
    Invest Cell Pathol; 1980; 3(4):415-6. PubMed ID: 7007299
    [No Abstract]   [Full Text] [Related]  

  • 31. Should dialysis patients ever receive warfarin and for what reasons?
    Bennett WM
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1357-9. PubMed ID: 17699369
    [No Abstract]   [Full Text] [Related]  

  • 32. New oral anticoagulants and risks in ENT.
    Hollis S
    Clin Otolaryngol; 2013 Aug; 38(4):355-7. PubMed ID: 23957550
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies for urgent reversal of target-specific oral anticoagulants.
    Davis EM; Uhlmeyer EM; Schmidt DP; Schardt GL
    Hosp Pract (1995); 2014 Dec; 42(5):108-25. PubMed ID: 25485923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influencing the effectiveness of repeatedly used dialyzers by the administration of ticlopidine (Ticlid)].
    Opatrný K; Cepelák V; Opatrný K; Racek J; Köcher P
    Vnitr Lek; 1986 Apr; 32(4):356-61. PubMed ID: 3727423
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethylene oxide allergy in patients on hemodialysis waiting for kidney transplantation: logistical nightmare or challenge? A case report.
    Monbaliu D; Van Breussegem A; Onsia A; Vandermeersch E; Segers C; Meert W; Kochuyt AM; Pirenne J; Claes K
    Transplant Proc; 2010 Dec; 42(10):4375-7. PubMed ID: 21168702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholestatic icterus and agranulocytosis due to ticlopidine].
    Saint-Marc Girardin MF; Cordonnier C
    Gastroenterol Clin Biol; 1982; 6(8-9):716-7. PubMed ID: 7129024
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholestatic jaundice associated with ingestion of ticlopidine: apropos of the first 2 cases].
    Deschamps JP; Lassègue A; Ottignon Y; Vuitton D; Allemand H; Carayon P; Miguet JP
    Gastroenterol Clin Biol; 1982; 6(6-7):595-6. PubMed ID: 7117772
    [No Abstract]   [Full Text] [Related]  

  • 39. At least two!
    Prescrire Int; 2013 Dec; 22(144):284. PubMed ID: 24600723
    [No Abstract]   [Full Text] [Related]  

  • 40. Margins.
    Prescrire Int; 2012 Nov; 21(132):256. PubMed ID: 23210251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.